Key facts
- It has raised $27.8M.
- Notable investors include Super Capital, Albo Club, DuF Investments, Dupe Ventures, Financière IDAT — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Ziwig
- ·The full record, as it builds
Funding rounds
No funding rounds for Ziwig are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ziwig
Operator of a diagnostics platform intended to detect the biological modifications responsible for the onset of diseases and their evolution throughout the life of patients. The company's platform uses salivary RNA and artificial intelligence to identify new biomarkers in saliva and diagnose several diseases, including endometriosis, cancer, and cardiovascular disease, enabling patients and healthcare providers to access an accurate, affordable, and accessible way to diagnose diseases.
- Sector
- Healthcare
- HQ
- Lyon, France
- Founded
- 2014
- Employees
- 121
- Website
- ziwig.com/
- Ownership
- Privately Held (backing)
Ziwig doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ziwig shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ziwig in its N-PORT filings yet. We sweep new filings monthly.